6D 60 DEGREES PHARMACEUTICALS, INC. Stock: price and management transactions · United States · SEC (Form 4) Follow the 60 DEGREES PHARMACEUTICALS, INC. share price and the full management transaction log of the company, a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €4.1m. The latest transaction was reported on 15 June 2026 (Acquisition). Among the most active insiders: DOW GEOFFREY S. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
Generate AI analysis AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 15 June 2026
All Executives22 Thresholds0 Prospectus0 Other0
Declarations 22 total
▲ President and CEO · Executives · 12 Jun 2026
7,350 shares Common Stock SEC:0001213900-26-068853:0
Canonical exit: 10 Sept 2026 (T+90) ▲ President and CEO · Executives · 15 Dec 2025
9,670 shares @ US$0.8024 11.7% of flow Common Stock SEC:0001213900-25-122379:0
Canonical exit: 15 Mar 2026 (T+90) ◆ Chief Operating Officer · Executives · 17 Jan 2025
4,540 shares 0Common Stock SEC:0001213900-25-076983:0
◆ President and CEO · Executives · 9 Jun 2025
4,376 shares @ US$2.9855 16.8% of flow Common Stock SEC:0001213900-25-052709:0
▲ Director · Executives · 3 Jun 2025
3,000 shares @ US$2.87 8.5% of flow Common Stock SEC:0001213900-25-051700:0
Canonical exit: 1 Sept 2025 (T+90) ◆ CFO · Executives · 17 Jan 2025
11,626 shares 0Common Stock SEC:0001213900-25-005051:0
◆ President and CEO · Executives · 17 Jan 2025
14,394 shares 0Common Stock SEC:0001213900-25-005055:0
▲ Director · Executives · 12 Dec 2024
2,500 shares @ US$1.85 5.4% of flow Common Stock SEC:0001213900-24-110269:0
Canonical exit: 12 Mar 2025 (T+90) ▲ President and CEO · Executives · 5 Dec 2024
17,549 shares @ US$1.1123 32.8% of flow Common Stock SEC:0001213900-24-107011:0
Canonical exit: 5 Mar 2025 (T+90) ▲ President and CEO · Executives · 19 Nov 2024
2,500 shares @ US$0.8992 3.7% of flow Common Stock SEC:0001213900-24-101110:0
Canonical exit: 17 Feb 2025 (T+90) ▲ Director · Executives · 27 Aug 2024
5,000 shares @ US$1.70 9.3% of flow Common Stock SEC:0001213900-24-077746:0
Canonical exit: 25 Nov 2024 (T+90) ◆ Director · Executives · 16 May 2024
4,000 shares @ US$0.223 100.0% of flow Common Stock SEC:0001213900-24-045708:0
◆ CFO · Executives · 16 May 2024
15,000 shares @ US$0.223 17.1% of flow Common Stock SEC:0001213900-24-045707:1
◇ Director · Executives · 16 May 2024
4,000 shares @ US$0.223 100.0% of flow Common Stock SEC:0001213900-24-045706:0
◇ Director · Executives · 16 May 2024
2,000 shares @ US$0.223 0.5% of flow Common Stock SEC:0001213900-24-045709:0
◇ Director · Executives · 16 May 2024
4,000 shares @ US$0.223 100.0% of flow Common Stock SEC:0001213900-24-045704:0
◇ President and CEO · Executives · 12 Apr 2024
68,000 shares @ US$0.2668 29.8% of flow Common Stock SEC:0001213900-24-045705:0
◆ CFO · Executives · 12 Apr 2024
60,000 shares @ US$0.2668 82.9% of flow Common Stock SEC:0001213900-24-045707:0
◇ President and CEO · Executives · 16 May 2024
17,000 shares @ US$0.223 6.2% of flow Common Stock SEC:0001213900-24-045705:1
45,560 shares @ US$4.745 100.0% of flow Common Stock, $0.0001 par value per share ("Common Shares") SEC:0001140361-24-017682:0
▲ President and CEO · Executives · 31 Jan 2024
25,974 shares @ US$0.375 15.8% of flow Common Stock SEC:0001213900-24-009603:0
Canonical exit: 30 Apr 2024 (T+90) ▲ Director · Executives · 31 Jan 2024
200,000 shares @ US$0.375 84.8% of flow Common Stock SEC:0001213900-24-009599:0
Canonical exit: 30 Apr 2024 (T+90) About 60 DEGREES PHARMACEUTICALS, INC. 60 DEGREES PHARMACEUTICALS, INC. is a company focused on developing innovative pharmaceutical treatments. It is listed on the XNAS market.